WHO WE ARE

AMPEL BioSolutions is a precision medicine company.  Profitability from in-house clinical trial design/management and AMPEL Genomic Platform (AGP®) fueled R&D for LuGENE®, a gene-based diagnostic for lupus patients to determine disease status, predict flares & match patients with best drug options.  Current customers are Pharma to accelerate trial success by enrolling patients into trials that express drug target/pathway.  Funding will scale and commercialize LuGENE® for the decision support markets (MD/patient and payors).  AMPEL's technology extends into other diseases.

RECENT NEWS

Dr Amrie Grammer @ Tom Tom Festival Oct 22,2020

Dr Amrie Grammer @ Tom Tom Festival Oct 22,2020

Machine Learning Approaches to Predict Lupus Disease Activity from Gene Expression Data The integration of gene expression data…

read more
Eight Innovative, Virginia Life Science Startups To Know. AMPEL Makes The List!

Eight Innovative, Virginia Life Science Startups to Know. AMPEL Makes the List!

At BioBuzz, we’re dedicated to bringing you interesting and important stories that emerge from the thriving life sciences…

read more
CBS19 News 5:00 & 6:00 Broadcast June 12, 2020

CBS19 News 5:00 & 6:00 Broadcast June 12, 2020

Charlottesville-based company develops COVID-19 testCHARLOTTESVILLE, Va. (CBS19 NEWS) -- A Charlottesville-based precision medical company has developed a new approach…

read more